A study of clinico-pathological parameters and O6- methylguanine DNA methyltransferase (MGMT) promoter methylation status in the prognostication of gliosarcoma-Reference-Cited by-同舟云学术

A study of clinico-pathological parameters and O6- methylguanine DNA methyltransferase (MGMT) promoter methylation status in the prognostication of gliosarcoma

Published:2012-03-01 Issue:5 Volume:32 Page:534-542
ISSN:0919-6544
Container-title:Neuropathology
language:en
Short-container-title:

Author:

Singh Geetika,Mallick Supriyo,Sharma Vikas,Joshi Nikhil,Purkait Suvendu,Jha Prerana,Sharma Mehar Chand,Suri Vaishali,Julka Pramod Kumar,Mahapatra Ashok Kumar,Singh Manmohan,Kale Shashank Sharad,Sarkar Chitra

Publisher

Wiley

Subject

Clinical Neurology,General Medicine,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1789.2012.01297.x/fullpdf

Reference27 articles.

1. Genetic profile of gliosarcomas;Reis;Am J Pathol,2000

2. Long-term survival with glioblastoma multiforme;Krex;Brain,2007

3. Frequent hypermethylation of the DNA repair gene MGMT in long-term survivors of glioblastoma multiforme;Martinez;J Neurooncol,2006

4. Reexamining the radiation therapy oncology group (RTOG) recursive partitioning analysis (RPA) for glioblastoma multiforme (GBM) patients;Shaw;Int J Radiat Oncol Biol Phys,2003

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic and predictive factors of secondary gliosarcoma: A single-institution series of 18 cases combined with 89 cases from literature;Frontiers in Oncology;2023-01-31

2. Prognostic Factors of Gliosarcoma in the Real World: A Retrospective Cohort Study;Computational and Mathematical Methods in Medicine;2023-01-30

3. Survival outcomes associated with MGMT promoter methylation and temozolomide in gliosarcoma patients;Journal of Neuro-Oncology;2022-04-26

4. Chasing a rarity: a retrospective single-center evaluation of prognostic factors in primary gliosarcoma;Strahlentherapie und Onkologie;2021-12-22

5. Prognostic value of test(s) for O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide;Cochrane Database of Systematic Reviews;2021-03-12